Skip to content

Stapler Post-market Observational Study

Assessing the Safety and Performance of the Endoscopic Linear Cutter Stapler in Laparoscopic Gastric Bypass Surgery.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02922205
Enrollment
100
Registered
2016-10-04
Start date
2017-04-06
Completion date
2020-09-16
Last updated
2020-11-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Observational

Brief summary

The purpose of this observational study is to evaluate the safety and performance of the Endoscopic Linear Cutter Stapler and reloads from Fengh Medical used in laparoscopic Roux-en-Y gastric bypass surgery to create anastomoses. The goal of the study will be achieved by assessing the device performance and reporting of peri- and postoperative complications in a prospectively maintained database.

Interventions

DEVICEEndoscopic Linear Cutter Stapler and reloads

Endoscopic Linear Cutter Stapler and reloads

Sponsors

Duomed
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age at study entry is at least 18 years. * Patient must sign and date the informed consent form prior to the index-procedure. * Patient has a BMI ≥ 35 kg/m with one or more related co-morbidity. * Patient has a BMI ≥ 40 kg/m.

Exclusion criteria

* Patient is pregnant. * History of bariatric surgery. * Patient is known to be, or suspected of being unable to comply with the study protocol or proposed follow-up visits.

Design outcomes

Primary

MeasureTime frameDescription
Number of patients with adverse events related to the index-procedure.1 month follow-upDetermination of postoperative anastomotic leaks and intraluminal/intraperitoneal bleeding.

Secondary

MeasureTime frameDescription
Number of adverse device effects.1, 6, 12 and 24 month follow-upDetermination of staple line disruption.
Number of patients with bariatric surgery related re-interventions.1, 6, 12 and 24 month follow-up
Percentage of excess weight loss.1, 6, 12 and month follow-uppre-operative weight (kg) minus postoperative weight (kg) divided by the ideal body weight (kg).
Questionnaire on food tolerance.1, 6, 12 and 24 month follow-up

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026